Hovione Farmaciencia, S.a.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Portugal
- Registered address
- Quinta Sao Pedro, Loures, 2674-506, Portugal (PRT)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3002807208 · DUNS 449818434
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-10-24
- VAIDrug Quality Assurance2023-03-10
- VAIDrug Quality Assurance2021-11-12
- NAIDrug Quality Assurance2017-11-03
- NAIDrug Quality Assurance2016-02-26
- VAIDrug Quality Assurance2014-12-05
- NAIDrug Quality Assurance2013-09-27
- NAIDrug Quality Assurance2011-04-29
- VAIDrug Quality Assurance2011-01-27
- VAIDrug Quality Assurance2009-09-25
Drugs this plant is listed as making
3 distinct drugs across 5 products name this site in their FDA label.
- ensifentrineMerck Sharp & Dohme Llc
- MinocyclineJourney Medical Corporation
- PlazomicinCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.